Alkermes is a leader in innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies our scientific expertise, proprietary technologies and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Track Record of Innovation
Through our proven scientific, development and manufacturing capabilities, Alkermes is uniquely positioned to be an engine of innovative treatments for major clinical conditions specifically focused on central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis.
The success of our approach is reflected in:
All this, combined with our resources and strong global presence, position us as a leading innovator in the global pharmaceutical market, today and for the future.
Alkermes ("AL-ker-meez") is a growing, global biopharmaceutical company, and our therapeutic focus is chronic diseases of the central nervous system (CNS). Our people are developing new medicines that address some of the most urgent public health and mental illness challenges today, including opioid addiction, depression, and schizophrenia.
We are in an exciting phase of growth with a portfolio of products available now and a pipeline of potential medicines in late-stage development. Our commercially available products include a long-acting injectable medication for the treatment of schizophrenia, and a non-addictive, once-monthly injectable medication for the treatment of alcohol dependence as well as for the prevention of relapse to opioid dependence, following opioid detoxification. In addition, we are making significant advances with a medicine candidate under development for the treatment of major depressive disorder.
Our vision is to help address some of the country’s major health priorities through expanding our scientific and business base. To help us achieve this, we need to expand our community of Alkermes employees in every part of the organization. We’re looking for scientists with a thirst for discovery and development, and professionals to engage with healthcare providers and get important information regarding disease treatments to patients; we’re expanding our field sales and marketing teams; we need public health policy experts and economists, and people with the skills to manufacture our medicines; and we need more of the people who keep Alkermes running as a thriving, high performing organization.
We’re proud of our growth and performance but even more proud of the people behind our success. We invite you to discover more about our company and our people, our values, our open positions, and how we strive to make a difference for patients living with addiction and other serious mental illness.
Hear directly from our CEO and our employees about the opportunity to join a passionate organization by viewing the below videos.
I have been working at Alkermes full-time (More than 3 years)
I have been here almost four years and it is a great place to work. I have friends in the industry and it seems that their companies do not compare any where close to what is happening at Alkermes.
I would like to see more flexible remote working. It is hit or miss currently depending on which department you work in.
Advice to Management
Have Richard Pops speak more. We love seeing his presentation. Maybe do monthly town halls.
I applied through a recruiter. The process took 3 weeks. I interviewed at Alkermes.
I went through a couple phone interviews and then two rounds of onsite interviews. Some of the questions were redundant, but it was good to speak with the different department heads about their perspective.